O'Shaughnessy Asset Management’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-972
Closed -$6K 1504
2021
Q3
$6K Sell
972
-42
-4% -$264 ﹤0.01% 2277
2021
Q2
$7K Sell
1,014
-64
-6% -$543 ﹤0.01% 2066
2021
Q1
$10K Buy
1,078
+981
+1,011% +$11.9K ﹤0.01% 1780
2020
Q4
$2K Buy
+97
New +$1.71K ﹤0.01% 1831

Other funds holding CRDF

O'Shaughnessy Asset Management's CRDF Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 972 shares — an estimated $6K sold.

O'Shaughnessy Asset Management first reported a position in CRDF in Q4 2020 and held it in 4 quarters. The position peaked at $10K in Q1 2021. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 972 Cardiff Oncology shares in Q4 2021, an estimated $6K.
  • O'Shaughnessy Asset Management first reported a position in Cardiff Oncology in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's Cardiff Oncology position peaked at $10K in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.